KORU Medical Systems Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

STOCK-BASED COMPENSATION (Tables)

4 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of fair value of the stock options granted Black-Scholes option valuation model

The risk-free interest rate was selected based upon yields of the U.S. Treasury issues with a term equal to the expected life of the option being valued:

	June 30,
	2017		2016

Dividend yield		0.00%		0.00%
Expected Volatility		59.00-72.2%		59.00%
Weighted-average volatility		—		—
Expected dividends		—		—
Expected term (in years)		4 - 5 Years		5 Years
Risk-free rate		2.17-2.48%		2.17%

Schedule of stock option plan

The following table summarizes the status of the Plan:

	Four Months Ended June 30,
	2017				2016
	Shares	Weighted Average Exercise Price			Shares		Weighted Average Exercise Price

Outstanding at March 1	1,345,000	$	0.39			1,060,000	$	0.37
Granted	18,000	$	—			—	$	—
Exercised	—	$	—			—	$	—
Forfeited	250,000	$	0.36			—	$	—
Outstanding at June 30	1,113,000	$	0.39			1,060,000	$	0.37
Options exercisable at June 30,	538,000	$	0.38			—	$	—
Weighted average fair value of options granted during the period	—	$	—			—	$	—
Stock-based compensation expense	—	$	(37,385	)		—	$	50,055

Schedule of information pertaining to options outstanding

The following table presents information pertaining to options outstanding at June 30, 2017:

Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price

$0.36 - $0.41	1,113,000	5 years	$	0.39	538,000	$	0.38